 |
Casma Therapeutics
Last updated: January 18, 2024
CEO Keith Dionne
Country: USA | Funding: $154.9M (+)
Website: https://www.casmatx.com/
Casma Therapeutics is a preclinical-stage therapeutics company focused on modulating the autophagy pathway to address unmet medical needs and transform the lives of patients.
Website: https://www.casmatx.com/
Casma Therapeutics is a preclinical-stage therapeutics company focused on modulating the autophagy pathway to address unmet medical needs and transform the lives of patients.